Close symbol

Main Content

People’s health is interconnected and interdependent with the health of our planet. We need to look after one, while taking care of the other. This means addressing our direct business footprint to minimise harm and maximise our sustainability. It also means acting on our indirect value chain.

As a healthcare company, we have the opportunity and the responsibility to play a part in the intersection between people and planetary health, building awareness and driving action. We are currently defining our long-term ambition in this space.

We have set two major milestones in our aim to improve the health of people and the planet by confirming our ambition to become a Net Zero business by 2040 and joining the UN-backed Race to Zero campaign .

To underpin this Net Zero ambition, we have set science-based targets for all emission scopes, which are aligned to keep global warming to no more than 1.5°C. These targets have been approved by the Science Based Targets initiative (SBTi) and they will ensure that Bupa makes transformational progress this decade.

The SBTi commended Bupa’s 1.5°C-aligned targets; currently the most ambitious designation available through the process and in-line with the levels required to meet the Paris agreement goals.

We are also joining the UN-backed Race to Zero campaign with Health Care Without Harm , the official Race to Zero healthcare partner, joining other organisations who have committed to take rigorous and immediate action to halve global emissions by 2030 and deliver a healthier, fairer zero carbon world in time.

net-zero-infographic

Bupa’s science-based targets

Bupa’s Scope 1, 2 and 3 targets approved by the SBTi are as follows:

  • We will reduce absolute Scope 1 and 2 greenhouse gas (GHG) emissions by 46.2% by 2030 from a 2019 base year with the ambition to become a net zero business across our direct operations. This will be achieved by increasing efficiencies, streamlining processes and adopting low carbon alternatives wherever possible, including renewable energy.
  • We commit to reduce absolute Scope 3 GHG emissions from purchased goods and services, insurance underwriting, business travel, downstream transportation and distribution by 63% by 2034 from a 2019 base year. This will be achieved through: digitisation of health treatments; working with suppliers and healthcare providers to decarbonise; developing technology strategies to reduce the carbon emissions of our technology operations by utilising public cloud services, and adopting digital technologies to reduce the carbon footprint of our business processes; and working in collaboration right across the industry to drive down the carbon of our value chain.
  • We commit to achieving science-based targets in corporate bonds, loans and equity by 2025 from a 2020 base year. Our portfolio targets cover around 40% of our total investment and lending activities by invested value. By 2040, our investment portfolio will be 1.5°C aligned. This will be achieved by decarbonising our financial investment portfolio by increasing investments in companies which have set science-based targets, reducing exposure to carbon-intensive sectors and investing in climate solutions. This target includes all of the asset classes required by SBTi. Our holdings of cash and government bonds are not currently included in the SBTi target methodology.

Environmental performance

Our latest environmental performance data is available in our 2021 Annual Report . For the last financial year, we reported in line with the Streamlined Energy and Carbon Reporting (SECR) requirements of a large unquoted UK company and reported our emissions for UK only. We will also publish our externally assured 2019, 2020 and 2021 global Scope 1 and 2 carbon footprints to demonstrate the progress made from our 2019 baseline year on bupa.com during 2022. These disclosures will include a progress update on our net zero ambitions and science-based targets, which were published in October 2021.